Accessibility Menu
Bluejay Diagnostics logo

Bluejay Diagnostics

(NASDAQ) BJDX

Current Price$1.43
Market Cap$3.03M
Since IPO (2021)-100%
5 YearN/A
1 Year-53%
1 Month+50%

Bluejay Diagnostics Financials at a Glance

Market Cap

$3.03M

Revenue (TTM)

$0.00

Net Income (TTM)

-$6.90M

EPS (TTM)

-$14.02

P/E Ratio

-0.21

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$1.43

Volume

2,832,721.576

Open

$2.91

Previous Close

$1.44

Daily Range

$1.13 - $2.91

52-Week Range

$1.13 - $16.68

Estimated Earnings Date

Aug 19, 2026

BJDX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Bluejay Diagnostics

Industry

Healthcare Equipment and Supplies

Employees

6

CEO

Indranil Dey, PhD, MBA

Headquarters

Acton, MA 01720, US

BJDX Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

-144.27%

Return on Capital

-114.07%

Return on Assets

-123.30%

Earnings Yield

-4.76%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$3.03M

Shares Outstanding

1.03M

Volume

2.83M

Avg. Volume

1.30M

Financials (TTM)

Gross Profit

-$98.37K

Operating Income

-$7.00M

EBITDA

-$6.73M

Operating Cash Flow

-$6.46M

Capital Expenditure

-$192.74K

Free Cash Flow

-$6.65M

Cash & ST Invst.

$3.68M

Total Debt

$97.03K

Bluejay Diagnostics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

-$49.56K

N/A

Gross Margin

0.00%

N/A

Market Cap

$3.03M

N/A

Market Cap/Employee

$433.10K

N/A

Employees

7

N/A

Net Income

-$1.92M

-2.9%

EBITDA

-$1.87M

-3.2%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$3.68M

+18.2%

Total Debt

$97.03K

-48.2%

Accounts Receivable

$0.00

-100.0%

Inventory

$0.00

N/A

Long Term Debt

$0.00

-100.0%

Short Term Debt

$97.03K

-3.0%

Return on Assets

-1.23%

N/A

Return on Invested Capital

-1.67%

N/A

Free Cash Flow

-$1.61M

-35.7%

Operating Cash Flow

-$1.59M

-34.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ELABPMGC Holdings Inc.
$1.21+6.14%
TIVCTivic Health Systems, Inc.
$0.54-2.52%
WINTWindtree Therapeutics, Inc.
$0.02+7.27%
MLECMoolec Science S.A.
$8.09+6.45%

Trending Stocks

Symbol / CompanyPricePrice Chg
CMCSAComcast
$24.22+0.05%
NOKNokia
$13.03+0.00%
SMCISuper Micro Computer
$28.15-0.08%
TAT&T
$21.82-0.04%

Questions About BJDX

What is the current price of Bluejay Diagnostics?

Bluejay Diagnostics is trading at $1.44 per share.

What is the 52-week range for Bluejay Diagnostics?

Over the past 52 weeks, Bluejay Diagnostics has traded between $1.13 and $16.68.

How much debt does Bluejay Diagnostics have?

As of the most recent reporting period, Bluejay Diagnostics reported total debt of $105.33K.

How much cash does Bluejay Diagnostics have on hand?

Bluejay Diagnostics reported $3.68M in cash and cash equivalents in its most recent financial results.

What is Bluejay Diagnostics’s dividend yield?

Bluejay Diagnostics does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.